Trademark Overview
On Friday, April 30, 2004, a trademark application was filed for RELINXIT with the United States Patent and Trademark Office. The USPTO has given the RELINXIT trademark a serial number of 78411638. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 5, 2005. This trademark is owned by ZymoGenetics, Inc.. The RELINXIT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations; sanitary preparations for medical purposes; materials for dressings; pharmaceutical preparations for the prevention and treatment of human diseases; adjuvants for use with vaccines; clotting agent, clotting preparation; diagnostic preparations for clinical or medical laboratory use; natural polymers for use in general surgery; pharmaceutical preparation for use in halting blood flow and medical procedures, enuresis and blood disorders; plasmin inhibitor; preparations for use as a topical hemostat to control surgical bleeding, for the prophylaxis and treatment of bleeding complications, and to make alterations in tissue repair associated with certain blood clotting deficiencies; protein involved in the stabilization and strengthening of blood clots developed for the treatment of bleeding complications associated with congenital and acquired deficiencies; preparations which are used either locally/topically or systemically for hemostatic control
